Fertility and Sterility
Volume 88, Issue 4 , Pages 906-910 , October 2007

Stage I ovarian carcinoma: different clinical pathologic patterns

  • Liane Deligdisch, M.D.

      Affiliations

    • The Mount Sinai School of Medicine, Department of Pathology, New York, New York
    • ,
  • Frédérique Pénault-Llorca, M.D., Ph.D.

      Affiliations

    • Centre de Lutte Contre le Cancer de la Région Auvergne, Department of Pathology, Clermont-Ferrand, France
    • ,
  • Peter Schlosshauer, M.D.

      Affiliations

    • The Mount Sinai School of Medicine, Department of Pathology, New York, New York
    • ,
  • Albert Altchek, M.D.

      Affiliations

    • The Mount Sinai School of Medicine, Department of Obstetrics, Gynecology and Reproductive Science, New York, New York
    • ,
  • Michele Peiretti, M.D.

      Affiliations

    • University of Cagliari, Department of Obstetrics and Gynecology, Cagliari, Italy
    • ,
  • Farr Nezhat, M.D.

      Affiliations

    • The Mount Sinai School of Medicine, Department of Obstetrics, Gynecology and Reproductive Science, New York, New York
    • Corresponding Author InformationCorrespondence to: Farr Nezhat, M.D., Department of Obstetrics, Gynecology and Reproductive Science, The Mount Sinai School of Medicine, 1176 5th Avenue, 9th floor, Box 1170, New York, NY 10029 (FAX: 212-987-6386).

Received 21 October 2006 ,Revised 22 December 2006 ,Accepted 22 December 2006.

References 

  1. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Washington, DC: Armed Forced Institute of Pathology; 1998;
  2. Scully RE. Histologic typing of ovarian tumors. World Health Organization international histologic classification of tumors. 2nd ed.. New York: Springer; 1999;
  3. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging handbook. 6th ed.. New York: Springer-Verlag; 2002;
  4. DiSaia PJ, Creasman WT. Epithelial ovarian cancer. In:  DiSaia PJ,  Creasman WT editor. Clinical gynecologic oncology. 6th ed.. St. Louis, MO: Mosby; 2002;p. 289–350
  5. Lee HR, Lennon VA, Camilleri M, Prather CM. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol. 2001;96:373–379
  6. Tidy J, Mason WP. Endometrioid carcinoma of the ovary: a retrospective study. Br J Obstet Gynecol. 1988;95:1165–1169
  7. Eisner RF, Nieberg RK, Berek JS. Synchronous primary neoplasms of the female reproductive tract. Gynecol Oncol. 1988;33:335–339
  8. Emmett-Buck MR, Shuang Z, Nogales F, Liotta LA, Merino M. Molecular analysis of synchronous uterine and ovarian tumors. Int J Gynecol Pathol. 1997;16:143–148
  9. Nezhat F, Nezhat C, Benigno B. Four ovarian cancers diagnosed during laparoscopic management of 1011 women with adnexal masses. Am J Obstet Gynecol. 1992;3:790–796
  10. McMeekin DS, Burger RA, Manetta A, DiSaia P, Berman ML. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. Gynecol Oncol. 1995;59:81–86
  11. Walsh C, Holschneider C, Heang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005;106:693–699
  12. Fukunaga M, Namura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumors. Histopathology. 1997;30:148–155
  13. Jiang X, Morland SI, Hitchock A, Thomas EJ, Campbell IE. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of common lineage. Cancer Res. 1998;58:1707–1712
  14. Kalir T, Nezhat F. Endometriosis and clues to the pathogenesis of ovarian cancer. CME J Gynecol Oncol. 2003;8:52–56
  15. Ogawa S, Kaku T, Amada S, Kobayashi H, Hirakawa T, Ariyoshi K, et al. Ovarian endometriosis associated with ovarian carcinoma: a clinical–pathologic and immunohistochemical study. Gynecol Oncol. 2000;77:298–304
  16. Nezhat F, Cohen CJ, Rahaman J, Cole P, Kalir T. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer. 2002;94:2935–2940
  17. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, et al. Genetic analysis of early- vs. late-stage ovarian tumors. Cancer Res. 2001;61:5895–5904
  18. Obata K, Morland SJ, Watson RH, Hitchcock A, Chenevix-Trench G, Thomas EJ, et al. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 1998;58:2095–2097
  19. Irving JA, Catasus L, Gallardo A, Bussaglia E, Romero M, Matias-Guiu X, et al. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis. Hum Pathol. 2005;36:605–619
  20. Catasus L, Bussaglia E, Rodriguez I, Gallardo A, Pons C, Irving JA, et al. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum Pathol. 2004;35:1360–1368
  21. Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suarez A, Armas A. Beta-catenin expression pattern in stage I and II ovarian carcinomas: relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol. 1999;155:527–536
  22. Berchuck A, Iversen ES, Lancaster JM, Pittman J, Luo J, Lee P, et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res. 2005;11:3686–3690

PII: S0015-0282(07)00067-2

doi: 10.1016/j.fertnstert.2006.12.035

Fertility and Sterility
Volume 88, Issue 4 , Pages 906-910 , October 2007

Article Tools